ARCH Venture Partners is a major venture capital firm with offices in Chicago, Seattle, and San Francisco that invests across life sciences, physical sciences, and advanced technology. The firm is known for building companies from foundational science, often around breakthrough discoveries emerging from academic or research institutions.

In neurotechnology and neuroscience, ARCH has backed companies such as Synchron and Neumora Therapeutics, reflecting strong conviction in both brain-computer interfaces and precision neuroscience platforms. Its model goes beyond passive investing and often includes deep involvement in company formation and long-term scaling.

ARCH invests globally but has its strongest footprint in the United States. It is one of the most relevant institutional investors for companies translating major neuroscience advances into clinically and commercially significant platforms.